We are live on ! Find out more
AA

Antipodean Advisors Portfolio holdings

AUM $19.5M
1-Year Est. Return 6.21%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$108M
AUM Growth
-$66.5M
Cap. Flow
-$35.4M
Cap. Flow %
-32.63%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$7.07M
2
ATRA icon
Atara Biotherapeutics
ATRA
+$2.81M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$27.3M
2
LK
Luckin Coffee Inc. American Depositary Shares
LK
+$11.3M
3
CVNA icon
Carvana
CVNA
+$4.64M
4
SE icon
Sea Limited
SE
+$2.06M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 47.29%
2 Technology 24.42%
3 Communication Services 21.17%
4 Consumer Staples 5.38%
5 Healthcare 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVT icon
1
Clarivate
CLVT
$1.37B
$26.5M 24.42%
1,275,000
– –
CDLX icon
2
Cardlytics
CDLX
$22.2M
$22.9M 21.17%
65,600
– –
CVNA icon
3
Carvana
CVNA
$47.5B
$21.5M 19.83%
1,950,000
-300,000
-13% -$4.64M
SE icon
4
Sea Limited
SE
$66.4B
$15.5M 14.32%
350,000
-46,000
-12% -$2.06M
AMZN icon
5
Amazon
AMZN
$2.44T
$14.2M 13.14%
146,060
+73,060
+100% +$7.07M
HLF icon
6
Herbalife
HLF
$1.3B
$5.83M 5.38%
200,000
– –
ATRA icon
7
Atara Biotherapeutics
ATRA
$72.6M
$1.88M 1.74%
+8,840
New +$2.81M
LK
8
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
– –
-286,000
Closed -$11.3M
MDCO
9
DELISTED
Medicines Co
MDCO
– –
-321,000
Closed -$27.3M

Similar funds

CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return

Antipodean Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Antipodean Advisors held 9 positions worth $108M, down 38% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Antipodean Advisors withdrew a net $35.4M in Q1 2020, closing 2 positions and reducing 2 holdings. Its most notable exit was Medicines Co, an estimated $27.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 47% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Antipodean Advisors opened a new position in Atara Biotherapeutics worth $1.88M.

  • Antipodean Advisors's largest Q1 2020 buy was Atara Biotherapeutics: 8,840 shares worth $1.88M.
  • Antipodean Advisors added most to Amazon in Q1 2020, an estimated $7.07M increase.
  • Antipodean Advisors's biggest Q1 2020 reduction was Carvana, cutting an estimated $4.64M.
  • Antipodean Advisors fully exited Medicines Co in Q1 2020, selling an estimated $27.3M.
  • Antipodean Advisors's ten largest holdings make up 100% of its $108M portfolio in Q1 2020.
  • Antipodean Advisors opened 1 new position and closed 2 in Q1 2020.
  • Antipodean Advisors's portfolio value fell 38% quarter-over-quarter to $108M.

Based on Antipodean Advisors's 13F filing for Q1 2020, filed 15 May 2020.